Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
|
|
|
|
|
1-10 employees
View all Aquinox Pharmaceuticals employees
|
|
|
IT Services and IT Consulting
|
|
|
604.629.9223
|
|
|
Vancouver, BC
|
|
|
2004
|
The decision makers in Aquinox Pharmaceuticals are David Main, Tom Macrury, etc. Click to Find Aquinox Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.